Thanks for joining us for the 2020 Global Conference on Regulatory Science!
READ MORE
Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
Featured Publications
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
News, Events, & Updates
Regulatory Science Forum: Fellows Showcase
Jan 24, 12pm-1:30pm
Harvard Medical School, Armenise 108
Twitter @Harvardmit_CRS
Are you a Senior Grant Manager looking to level up? HiTS is Hiring an Assistant Director of Finance to oversee a 3 person grants and finance team. This is a great stepping stone to senior sponsored research administration roles! Re…https://lnkd.in/dxbV_DS https://lnkd.in/d2mSSVn
Today's @HarvardMIT_CRS meeting also features a presentation from @AleAviP @dfcidatascience, "Data Sources and Misclassification Methods for Paclitaxel Signal Discernment" #RegSci2020
At today's @HarvardMIT_CRS meeting, @argMaxRusso @dfcidatascience presents "Using auxiliary variables in testing multiple hypotheses" #RegSci2020
Happy Thanksgiving!
I celebrated by giving a talk at UCL, I had a really nice time!
Thanks @fx_briol for the invitation!
A must read! Congratulations @PlanaDeborah and Adam for publishing this outstanding research @HiTSatHarvard https://twitter.com/PlanaDeborah/status/1329446279810850823
Our work out now in @CellSystemsCP! Analysis of patient data using permutation testing with empirical null distributions identifies overlooked and promising therapeutic opportunities in oncology @HMS_SysBio @HarvardMITmdphd @harvardmed @mit_hst https://twitter.com/CellSystemsCP/status/1329433497958719489